Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Via Pharmaceuticals Inc. (VIAP) had Weighted-Average Shares Outstanding (Diluted) of 20.59M for the most recently reported fiscal quarter, ending 2010-12-31.
| Income Statement Financials | |
-- |
|
$-2.47M |
|
-- |
|
-- |
|
$0.90M |
|
$-0.90M |
|
$-1.59M |
|
$-2.49M |
|
$-2.49M |
|
$-2.49M |
|
$-2.47M |
|
$-2.47M |
|
$-2.49M |
|
$-0.90M |
|
$0.11M |
|
20.59M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
20.59M |
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$0.44M |
|
-- |
|
$0.03M |
|
$0.49M |
|
$18.98M |
|
-- |
|
$0.01M |
|
$18.99M |
|
$-18.50M |
|
$-18.50M |
|
$-18.49M |
|
-- |
|
| Cash Flow Statement Financials | |
$-6.10M |
|
$0.00M |
|
$4.00M |
|
$2.19M |
|
$0.08M |
|
$-2.10M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.02 |
|
-- |
|
-- |
|
-- |
|
-0.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
13.36% |
|
13.36% |
|
-504.29% |
|
13.36% |
|
-- |
|
$-0.30 |
|
$-0.30 |
|